The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial on the intra- and post-operative intracranial administration of ipilimumab and nivolumab in patients with recurrent high-grade glioma.
 
Bart Neyns
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Pierre Fabre
 
Iris Dirven
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pierre Fabre
 
Louise Lescrauwaet
No Relationships to Disclose
 
Jacomi Del'haye
No Relationships to Disclose
 
Wietse Geens
No Relationships to Disclose
 
Xenia Geeraerts
No Relationships to Disclose
 
Latoya Stevens
No Relationships to Disclose
 
Stefanie Brock
No Relationships to Disclose
 
Mark Kockx
Leadership - CellCarta
Stock and Other Ownership Interests - CellCarta
 
Laura Seynaeve
No Relationships to Disclose
 
Hendrik Everaert
No Relationships to Disclose
 
Anne-Marie Vanbinst
No Relationships to Disclose
 
Sandra Tuyaerts
No Relationships to Disclose
 
Johnny Duerinck
No Relationships to Disclose